Moreover, IRF-4 transactivates the expression of Myc (which encodes the proto-oncoprotein c-Myc) in MM and vice versa, thereby forming a regulatory loop that enforces high IRF-4 (22, 23). Here, IRF4 is linked to Miyoshi myopathy.